查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
心臟手术设备全球市场-2022-2029
市场调查报告书
商品编码
1140762

心臟手术设备全球市场-2022-2029

Global Cardiac Surgery Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

在预测期间（2022-2029 年），心臟手术设备市场预计将达到 8.4% 的复合年增长率。

心臟外科医生对先天性心脏病、缺血性心脏病和瓣膜性心脏病等心臟并发症进行心臟手术。心臟设备製造商正在开发除现有设备之外的新设备，以提供治疗心脏病的更多有用产品。

市场动态

主要驱动因素是心脏病发病率上升、人口老龄化和技术进步。

心血管疾病患病率的上升和老年人口的增加正在推动全球市场的增长。

预计心血管疾病发病率的增加将在预测期内提振市场。例如，根据英国心臟基金会的数据，2020 年将有大约 168,319 人死于心血管疾病。由于各种诱发因素，心血管疾病呈上升趋势。老年人口不断增加，可支配收入增加，生活方式改变，吸烟等等。据显示有1亿人。到2050年，预计老年人口将达到21亿。此外，根据世界卫生组织 (WHO) 的数据，烟草消费每年导致超过 800 万人死亡，其中约 700 万人来自直接烟草使用，约 120 万人为二手烟民。这被认为是接触的结果吸烟。

严格的法规和心臟外科医生的短缺正在阻碍全球心臟手术设备市场的增长。

然而，对医疗器械审批的严格规定、高昂的投资成本以及专业和熟练外科医生的短缺预计将阻碍市场。执行心臟手术的熟练外科医生短缺可能会限制市场。

行业分析。

《全球心臟手术器械市场报告》根据波特五力、创新、新产品发布、定价和流行病学分析等各种行业因素对市场进行了深入分析。

细分分析

预计在预测期内（2022-2029 年），微创手术领域的需求将很高。

预计微创手术领域将在预测期内（2022-2029 年）提振市场。微创心臟手术因其各种好处而越来越受欢迎，包括更少的手术创伤和更少的手术部位疼痛。此外，预计微创手术方法的最新进展将推动市场发展。例如，在机器人辅助心臟手术中，外科医生在胸部一侧做一个或多个小切口，并引导机械臂通过这些切口。机器人显示出清晰的心臟图像，外科医生控制机械臂进行手术。

区域分析

预计北美将主导全球心臟手术设备市场。

北美在 2021 年主导了全球心臟手术设备市场。据估计，心血管疾病发病率的上升、技术的快速进步、人群意识的增强以及对微创手术的日益偏好将在预测期内（2022-2029 年）保持巨大的市场规模。预计心血管疾病发病率的增加将在预测期内推动市场。例如，根据 CDC 的数据，每 34 秒就有一名美国人死于心血管疾病，而 2020 年将有 697,000 名美国人死于心血管疾病。此外，每 40 秒就有一名美国人死于心血管疾病。冠心病占心血管疾病死亡的大部分，其次是中风和心力衰竭。疾病预防控制中心估计，心脏病是美国的首要死因，造成五分之一的死亡。因此，心血管疾病的增加正在推动心臟手术设备市场。

竞争格局

在全球心臟手术设备市场运营的主要公司有 Medtronic、LivaNova plc、Terumo Corporation、Edwards Lifesciences Corporation、Boston Scientific Corporation、Abbott Laboratories、Getinge、Delacroix-Chevalier、Wexler Surgical、Rumex International 等。主要参与者正在采取各种策略，如产品发布、併购、合作伙伴和联盟，这有助于全球心臟手术器械市场的增长。例如，2022 年 4 月 8 日，LivaNova 开始有针对性地商业推出体外循环患者监护仪 Essenz。同样在 2022 年 7 月 21 日， Terumo India 与 Sensible Medical Innovations 建立了新的战略商业分销合作伙伴关係。

Medtronic, Plc.

是一个概述。

Medtronic PLC 是一家总部位于爱尔兰的美国医疗器械製造商。美敦力成立于 1949 年，总部位于美国明尼苏达州明尼阿波利斯。美敦力经营四项业务：微创治疗组、糖尿病组、恢復性治疗组和心血管组。

产品介绍。

Medtronic, Plc.的产品组合。心臟手术产品组合包括 Aquamantys 双极封口机、单极封口机、PlasmaBlade 解剖装置、Cardioblate 68000 手术消融系统发生器、Cardioblate 手术消融笔、Cardioblate(TM) BP2、Cardioblate LP 等。

全球心臟外科设备市场报告将提供对大约 40 多个市场数据表、45 多个数字和 200 页（大约）的区域的访问。

目录

第一章 调查方法和范围

  • 调查方法
  • 调查目的和范围

第二章市场定义和概述

第三章执行摘要

第四章市场动态

  • 市场影响因素
    • 促进者
      • 心脑血管疾病增加
      • 老年人口增加
      • 市场策略
    • 抑製剂
      • 心臟外科医生短缺
      • 严格监管
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 中的价格动态
  • 供需谱
  • 大流行期间与市场相关的政府努力
  • 製造商的战略举措
  • 概括

第 7 章按产品类型

  • 心臟外科搏动系统
    • 稳定剂
    • 定位器
  • 灌注式一次性
    • 氧气发生器
    • 离心泵
    • 心肌梗塞治疗仪
  • 心肺机
  • 导管
    • 消融导管
    • 引流导管

第8章技术

  • 冠状动脉搭桥手术
  • 微创手术

第 9 章 按类型

  • 介入心臟手术
  • 心率管理
  • 常规心臟手术
  • 其他

第 10 章最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东/非洲

第十二章 竞争格局

  • 主要发展和战略
  • 公司股份分析
  • 产品基准

第十三章公司简介

  • Medtronic Plc
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务概览
  • LivaNova plc
  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Getinge
  • Delacroix-Chevalier
  • Wexler Surgical
  • Rumex International

第 14 章 数据管理

简介目录
Product Code: DMMD2192

Market Overview

Cardiac Surgery Devices Market is estimated to reach at a CAGR of 8.4% during the forecast period (2022-2029).

Heart surgeons perform cardiac surgery due to the complications in the heart like congenital heart disease, ischemic heart disease, valvular heart disease, etc. Manufacturers of cardiac devices are developing novel instruments along with traditional devices to offer more usable products in treating cardiac diseases.

Market Dynamics

The major driving forces are the rising heart disease prevalence, the growing geriatric population, and technological advancements.

The increasing prevalence of cardiovascular disease and rising geriatric population are propelling the global market growth.

The increasing incidences of cardiovascular diseases are expected to boost the market over the forecast period. For instance, according to the British Heart Foundation, around 168,319 people died in 2020 from cardiovascular diseases. Cardiovascular diseases are rising due to various predisposing factors; examples of a few are the growing geriatric population, rising disposable income, changing lifestyles, smoking, and others; for instance, the world health organization data indicated that in 2020, there were around 1 billion people aged 60 and above. It is estimated that by 2050 the geriatric population will reach 2.1 billion. In addition to this, as per the World Health Organization, tobacco consumption has claimed over 8 million deaths every year globally, of which nearly 7 million are because of the direct use of tobacco, while close to 1.2 million are as a result of non-smokers exposed to secondhand smoke.

The stringent regulations and lack of cardiac surgeons hinder the global cardiac surgery devices market growth.

However, the stringent regulations for the approval of medical devices, high investment cost, and shortage of professional/skilled surgeons are expected to hamper the market. The shortage of skilled surgeons to perform cardiac surgeries is likely to restrain the market.

Industry analysis.

The global cardiac surgery devices market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, epidemiological analysis, Etc.

Segment Analysis

The minimally invasive surgery segment is predicted to have a high demand during the forecast period (2022-2029).

The minimally invasive surgery segment is expected to boost the market over the forecast period (2022-2029). Minimally invasive cardiac surgery has surged in popularity because of the various benefits of this procedure, like reduced surgical trauma and decreased pain in the surgical area. Also, recent advancements in minimally invasive surgical approaches are expected to boost the market. For instance, Robotically assisted heart surgery is where the surgeon makes one or more small incisions in the side of the chest and guides robotic arms through these incisions. The robot shows clear images of the heart, and the surgeon controls the robotic arms to perform the procedure.

Geographical Analysis

North America is predicted to command the global cardiac surgery devices market.

North America dominated the global cardiac surgery devices market in 2021. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to the increasing incidences of cardiovascular diseases, rapid technological advances, increasing awareness among the population, and the growing preference for minimally invasive procedures. The increasing incidences of cardiovascular diseases are expected to drive the market over the forecast period. For instance, according to the CDC, every 34 seconds, a U.S. American dies because of cardiovascular disease; in 2020, 697,000 American deaths were caused by cardiovascular disease. Also, among Americans, one person dies from cardiovascular disease every 40 seconds. Coronary heart disease accounts for most CVD deaths, followed by stroke and heart failure. CDC has estimated that heart disease is the leading cause of death in the U.S. and is responsible for 1 in every 5 deaths. Thus, the growing number of cardiovascular diseases drives the cardiac surgery devices market.

Competitive Landscape

The major players operating in the global cardiac surgery devices market are Medtronic, LivaNova plc, Terumo Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, Getinge, Delacroix-Chevalier, Wexler Surgical, Rumex International. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the cardiac surgery devices market globally. For instance, on Apr 08, 2022, LivaNova initiated a targeted commercial launch of the Essenz patient monitor for cardiopulmonary bypass procedures. Also, on July 21, 2022, Terumo India signed a new strategic commercial distribution partnership with Sensible Medical Innovations.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The product portfolio of Medtronic, Plc. The product portfolio for Cardiac Surgery Devices contains Aquamantys bipolar sealers, Monopolar sealers, PlasmaBlade dissection devices, Cardioblate 68000 Surgical Ablation System Generator, Cardioblate Surgical Ablation Pens, Cardioblate™ BP2 , Cardioblate LP, Etc.

The global cardiac surgery devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Growing Prevalence of Cardio Vascular Diseases
      • 4.1.1.2. Growing Geriatric Population
      • 4.1.1.3. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Cardiac Surgeons
      • 4.1.2.2. Stringent Regulation
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Beating Heart Surgery Systems
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
      • 7.2.2.1. Stabilizers
      • 7.2.2.2. Positioners
  • 7.3. Perfusion Disposables
    • 7.3.1. Oxygenators
    • 7.3.2. Centrifugal Pumps
    • 7.3.3. Cardioplegia Delivery Systems
  • 7.4. Cardiopulmonary Bypass Equipment
  • 7.5. Catheters
    • 7.5.1. Ablation Catheter
    • 7.5.2. Drainage Catheter

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Segment
    • 8.1.2. Market Attractiveness Index, By Procedure Segment
  • 8.2. Coronary Artery Bypass Grafting
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Minimally Invasive Surgery

9. By Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 9.1.2. Market Attractiveness Index, By Type Segment
  • 9.2. Interventional Cardiac Surgery
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Cardiac Rhythm Management
  • 9.4. Traditional Cardiac Surgery
  • 9.5. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. LivaNova plc
  • 13.3. Terumo Corporation
  • 13.4. Edwards Lifesciences Corporation
  • 13.5. Boston Scientific Corporation
  • 13.6. Abbott Laboratories
  • 13.7. Getinge
  • 13.8. Delacroix-Chevalier
  • 13.9. Wexler Surgical
  • 13.10. Rumex International

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us